Graft SurvivalKidney TransplantationCorneal TransplantationGraft RejectionHeart TransplantationTissue DonorsCorneal NeovascularizationSurvival RateTransplantation, HomologousLiver TransplantationCell SurvivalTreatment OutcomeTime FactorsImmunosuppressive AgentsProportional Hazards ModelsSurvival AnalysisDisease-Free SurvivalRetrospective StudiesMice, Inbred C57BLCadaverTransplantsSurvivalLiving DonorsTissue and Organ ProcurementTacrolimusFollow-Up StudiesCyclosporineImmunosuppressionHistocompatibility TestingPostoperative ComplicationsKaplan-Meier EstimatePancreas TransplantationGraft Occlusion, VascularKeratoplasty, PenetratingMycophenolic AcidTransplantationSkin TransplantationIslets of Langerhans TransplantationCold IschemiaLiver FailureRisk FactorsTransplantation ToleranceKidney Failure, ChronicTransplantation, HeterotopicDelayed Graft FunctionLung TransplantationReoperationBrain DeathTransplantation ImmunologyOrgan PreservationAntilymphocyte SerumWaiting ListsMultivariate AnalysisRecurrencePrognosisBone Marrow TransplantationPrimary Graft DysfunctionProspective StudiesIsoantibodiesHLA AntigensGraft Enhancement, ImmunologicFetal Tissue TransplantationDeathKidneyRats, Inbred LewHistocompatibilityMice, Inbred BALB CCohort StudiesBlood Vessel ProsthesisBiopsyNeoplasm StagingAge FactorsApoptosisTransplantation, IsogeneicCreatinineCombined Modality TherapyIncidenceRisk AssessmentGraft vs Host DiseaseBrain Tissue TransplantationAntineoplastic Combined Chemotherapy ProtocolsAzathioprineRegistriesOrgan Preservation SolutionsActuarial AnalysisHematopoietic Stem Cell TransplantationTransplantation, AutologousAcute DiseaseImmunohistochemistryAntibodies, MonoclonalDrug Therapy, CombinationTissue and Organ HarvestingPolytetrafluoroethyleneAnastomosis, SurgicalSirolimusPrednisoneCytomegalovirus InfectionsComplement C4bPredictive Value of TestsKidney Diseases